Proteome Sciences (LON:PRM) Releases Earnings Results

Proteome Sciences (LON:PRM) issued its quarterly earnings results on Thursday. The company reported GBX (1.15) (($0.01)) earnings per share for the quarter, Digital Look Earnings reports. Proteome Sciences had a negative return on equity of 0.01% and a negative net margin of 0.04%.

Proteome Sciences Trading Down 11.0 %

Proteome Sciences stock opened at GBX 3.16 ($0.04) on Thursday. The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66. The stock has a market cap of £9.33 million, a PE ratio of -2.29 and a beta of 0.07. The stock has a 50-day moving average price of GBX 4.08 and a 200 day moving average price of GBX 3.46. Proteome Sciences has a 52 week low of GBX 2.22 ($0.03) and a 52 week high of GBX 5.40 ($0.07).

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.